Benjamin Powers

1.1k total citations
15 papers, 171 citations indexed

About

Benjamin Powers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Benjamin Powers has authored 15 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Benjamin Powers's work include Sarcoma Diagnosis and Treatment (8 papers), Vascular Tumors and Angiosarcomas (3 papers) and Protein Degradation and Inhibitors (3 papers). Benjamin Powers is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Vascular Tumors and Angiosarcomas (3 papers) and Protein Degradation and Inhibitors (3 papers). Benjamin Powers collaborates with scholars based in United States, Malaysia and Italy. Benjamin Powers's co-authors include Megan Othus, Charles D. Blanke, Sandip Pravin Patel, Mark Agulnik, Razelle Kurzrock, Young Kwang Chae, Elad Sharon, Chris Ryan, Suresh Nair and Michael J. Wagner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Benjamin Powers

14 papers receiving 171 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Benjamin Powers 118 97 41 34 30 15 171
Claudia Maria Valverde Morales 86 0.7× 113 1.2× 28 0.7× 20 0.6× 16 0.5× 13 152
Rocco Giannicola 99 0.8× 62 0.6× 11 0.3× 17 0.5× 34 1.1× 16 196
Bérengère Dadone‐Montaudié 56 0.5× 73 0.8× 14 0.3× 21 0.6× 39 1.3× 23 146
Alethia Álvarez‐Cano 110 0.9× 70 0.7× 13 0.3× 13 0.4× 47 1.6× 10 175
Luke Mountjoy 86 0.7× 28 0.3× 14 0.3× 14 0.4× 18 0.6× 16 148
Carole Massabeau 68 0.6× 56 0.6× 14 0.3× 78 2.3× 30 1.0× 32 196
A. Qin 208 1.8× 149 1.5× 7 0.2× 19 0.6× 32 1.1× 20 286
Ornella Nicoletto 69 0.6× 41 0.4× 18 0.4× 35 1.0× 78 2.6× 15 180
Mohammed Harb 126 1.1× 46 0.5× 7 0.2× 24 0.7× 72 2.4× 9 194
Sheik Emambux 105 0.9× 77 0.8× 6 0.1× 29 0.9× 36 1.2× 13 174

Countries citing papers authored by Benjamin Powers

Since Specialization
Citations

This map shows the geographic impact of Benjamin Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Powers more than expected).

Fields of papers citing papers by Benjamin Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Powers. The network helps show where Benjamin Powers may publish in the future.

Co-authorship network of co-authors of Benjamin Powers

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Powers. A scholar is included among the top collaborators of Benjamin Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Powers. Benjamin Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Patel, Sandip Pravin, Young Kwang Chae, Shiruyeh Schokrpur, et al.. (2025). Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma. npj Precision Oncology. 9(1). 24–24. 1 indexed citations
2.
Chae, Young Kwang, Megan Othus, Sandip Pravin Patel, et al.. (2024). Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors. Journal for ImmunoTherapy of Cancer. 12(9). e009128–e009128. 2 indexed citations
3.
Ingham, Matthew, Li Chen, Biswajit Das, et al.. (2024). Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS).. Journal of Clinical Oncology. 42(16_suppl). 11526–11526. 3 indexed citations
4.
Patel, Sandip Pravin, Young Kwang Chae, Michael J. Dennis, et al.. (2024). SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer. Cancer. 130(17). 2918–2927. 10 indexed citations
5.
Lee, Shing M., Mihaela Druta, Anthony P. Conley, et al.. (2023). ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11531–11531. 1 indexed citations
6.
Larson, Kelsey E., et al.. (2022). Clinical Impact of Systemic Staging Studies in Secondary Breast Angiosarcoma. SHILAP Revista de lepidopterología. 10. 100081–100081.
7.
8.
Wagner, Michael J., Megan Othus, Sandip Pravin Patel, et al.. (2021). Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). Journal for ImmunoTherapy of Cancer. 9(8). e002990–e002990. 106 indexed citations
9.
Oza, Jay, Brittany L. Siontis, Benjamin Powers, et al.. (2021). A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.. Journal of Clinical Oncology. 39(15_suppl). TPS11578–TPS11578. 5 indexed citations
10.
Martín‐Broto, Javier, Antonio López–Pousa, Andrew S. Brohl, et al.. (2020). Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Molecular Cancer Therapeutics. 20(1). 132–141. 9 indexed citations
11.
Powers, Benjamin, et al.. (2018). Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy. Journal of Oncology Pharmacy Practice. 25(7). 1784–1786. 6 indexed citations
12.
Sharma, Priyanka, Benjamin Powers, Bruce F. Kimler, et al.. (2015). Abstract P3-06-16: Thrombocytopenia is associated with pathological complete response to neoadjuvant carboplatin/docetaxel chemotherapy in BRCA wild type triple negative breast cancer. Cancer Research. 75(9_Supplement). P3–6. 1 indexed citations
13.
Borrego-Diaz, Emma, Benjamin Powers, Vugar Azizov, et al.. (2014). A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer. International Journal of Oncology. 45(6). 2421–2429. 19 indexed citations
14.
Woodroof, Janet, et al.. (2014). CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases. Dermatology Online Journal. 20(7). 2 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Maria Valverde Morales Breakdown of academic impact, for papers by Rocco Giannicola Breakdown of academic impact, for papers by Bérengère Dadone‐Montaudié Breakdown of academic impact, for papers by Alethia Álvarez‐Cano Breakdown of academic impact, for papers by Luke Mountjoy Breakdown of academic impact, for papers by Carole Massabeau Breakdown of academic impact, for papers by A. Qin Breakdown of academic impact, for papers by Ornella Nicoletto Breakdown of academic impact, for papers by Mohammed Harb Breakdown of academic impact, for papers by Sheik Emambux
Rankless by CCL
2026